These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 22244416

  • 1. Hepatocyte growth factor and omega-3-enriched feeds have a synergistic effect on mucosal mass in an animal model of inflammatory bowel disease.
    Katz MS, Thatch KA, Schwartz MZ.
    J Pediatr Surg; 2012 Jan; 47(1):194-8. PubMed ID: 22244416
    [Abstract] [Full Text] [Related]

  • 2. Gene alterations and intestinal mucosal changes following growth factor and omega-3 exposure in a rat model of inflammatory bowel disease.
    Katz MS, Thatch KA, Schwartz MZ.
    J Pediatr Surg; 2013 Feb; 48(2):345-52. PubMed ID: 23414863
    [Abstract] [Full Text] [Related]

  • 3. Chronology of the effect of massive small bowel resection and hepatocyte growth factor (HGF) on intestinal adaptation.
    Katz MS, Thatch KA, Schwartz MZ.
    J Surg Res; 2011 Dec; 171(2):399-403. PubMed ID: 21658720
    [Abstract] [Full Text] [Related]

  • 4. Growth factor manipulation of intestinal angiogenesis: a possible new paradigm in the management of inflammatory bowel disease.
    Thatch KA, Mendelson KG, Haber MM, Schwartz MZ.
    J Surg Res; 2009 Oct; 156(2):245-9. PubMed ID: 19524260
    [Abstract] [Full Text] [Related]

  • 5. Is OM-3 synergistic with GLP-2 in intestinal failure?
    Karmaker A, Costanzo CM, Schwartz MZ.
    J Surg Res; 2017 Jan; 207():7-12. PubMed ID: 27979490
    [Abstract] [Full Text] [Related]

  • 6. Influence of luminal hepatocyte growth factor on small intestine mucosa in vivo.
    Kato Y, Yu D, Lukish JR, Schwartz MZ.
    J Surg Res; 1997 Jul 15; 71(1):49-53. PubMed ID: 9271277
    [Abstract] [Full Text] [Related]

  • 7. Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease.
    Arthur LG, Schwartz MZ, Kuenzler KA, Birbe R.
    J Pediatr Surg; 2004 Feb 15; 39(2):139-43; discussion 139-43. PubMed ID: 14966727
    [Abstract] [Full Text] [Related]

  • 8. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2.
    Alavi K, Schwartz MZ, Palazzo JP, Prasad R.
    J Pediatr Surg; 2000 Jun 15; 35(6):847-51. PubMed ID: 10873024
    [Abstract] [Full Text] [Related]

  • 9. [Effect of combined therapy of granulocyte colony stimulating factor and bone marrow mesenchymal stem cells carrying hepatocyte growth factor gene on angiogenesis of myocardial infarction in rats].
    Guo Y, Liu C, He J.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun 15; 25(6):736-40. PubMed ID: 21735790
    [Abstract] [Full Text] [Related]

  • 10. Hepatocyte growth factor increases glucagon immunoreactivity in jejunal cells during intestinal adaptation.
    Timmapuri SJ, Otterburn DM, Arafat H, Schwartz MZ.
    J Pediatr Surg; 2006 Jan 15; 41(1):150-4; discussion 150-4. PubMed ID: 16410125
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of hepatocyte growth factor on intestinal permeability and bacterial translocation after small bowel transplantation in rat].
    Li K, Li N, Li J.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May 15; 21(5):532-5. PubMed ID: 17578297
    [Abstract] [Full Text] [Related]

  • 13. Effect of dietary fat on intestinal inflammatory diseases.
    Hokari R, Matsunaga H, Miura S.
    J Gastroenterol Hepatol; 2013 Dec 15; 28 Suppl 4():33-6. PubMed ID: 24251701
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enteral glutamine does not enhance the effects of hepatocyte growth factor in short bowel syndrome.
    Alavi K, Kato Y, Yu D, Schwartz MZ.
    J Pediatr Surg; 1998 Nov 15; 33(11):1666-9. PubMed ID: 9856891
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of intestinal adaptation by hepatocyte growth factor.
    Kato Y, Yu D, Schwartz MZ.
    J Pediatr Surg; 1998 Feb 15; 33(2):235-9. PubMed ID: 9498393
    [Abstract] [Full Text] [Related]

  • 17. Lipopolysaccharide potentiates the effect of hepatocyte growth factor on hepatocyte replication in rats by augmenting AP-1 activity.
    Gao C, Jokerst R, Gondipalli P, Cai SR, Kennedy S, Flye MW, Ponder KP.
    Hepatology; 1999 Dec 15; 30(6):1405-16. PubMed ID: 10573519
    [Abstract] [Full Text] [Related]

  • 18. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
    Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H, Nishikawa T, Tamai K, Azuma N, Sasajima T, Kaneda Y.
    Circulation; 2006 Sep 12; 114(11):1177-84. PubMed ID: 16952986
    [Abstract] [Full Text] [Related]

  • 19. Hepatocyte growth factor-induced amelioration in renal interstitial fibrosis is associated with reduced expression of alpha-smooth muscle actin and transforming growth factor-beta1.
    Wang HY, Wang YJ, Cui MJ, Gu CM, Yang LZ, Zhao Y, Chen Y, Zhao D, Li TS, Chi BR.
    Indian J Biochem Biophys; 2011 Oct 12; 48(5):308-15. PubMed ID: 22165288
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.